Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Portugal Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20072
20081
20091
20112
20194
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Theravance Biopharma3
Bial - Portela C S.A.2
Solvay Pharmaceuticals2
AbbVie1
AbbVie (prior sponsor, Abbott)1
Eisai Limited1
Hoffmann-La Roche1
NeuroDerm Ltd.1
Newron Pharmaceuticals SPA1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease14
Dizziness3
Dyskinesias3
Hypotension3
Pure Autonomic Failure3
Syncope3
Hypotension, Orthostatic2
Parkinsonian Disorders2
Multiple System Atrophy1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.